Filing Details
- Accession Number:
- 0001753926-24-000984
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-15 16:39:19
- Reporting Period:
- 2024-05-14
- Accepted Time:
- 2024-05-15 16:39:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1347242 | Lipella Pharmaceuticals Inc. | LIPO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1959250 | H Jonathan Kaufman | C/O Lipella Pharmaceuticals Inc. 7800 Susquehanna St., Suite 505 Pittsburgh PA 15208 | See Remarks Below. | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-14 | 10,000 | $0.76 | 898,849 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Open market purchase by the reporting person of 10,000 shares of common stock, par value $0.0001 per share (the "Common Stock").
- Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on May 14, 2024 at prices ranging from $0.7552 to $0.76 per share, inclusive. The amount reflected has been rounded to 3 decimal points.
- The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.
Billionaire Hedge Funds
